Ropinirole Hydrochloride Patent Expiration
Ropinirole Hydrochloride is used for treating Parkinson's syndrome. It was first introduced by Glaxosmithkline Llc
Ropinirole Hydrochloride Patents
Given below is the list of patents protecting Ropinirole Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
---|---|---|---|---|
Requip Xl | US7927624 | Hydrophilic/lipophilic polymeric matrix dosage formulation |
Dec 02, 2021
(Expired) | Glaxosmithkline Llc |
Requip Xl | US8303986 | Hydrophilic/lipophilic polymeric matrix dosage formulation |
Apr 12, 2021
(Expired) | Glaxosmithkline Llc |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Ropinirole Hydrochloride's patents.
Latest Legal Activities on Ropinirole Hydrochloride's Patents
Given below is the list recent legal activities going on the following patents of Ropinirole Hydrochloride.
Activity | Date | Patent Number |
---|---|---|
Maintenance Fee Reminder Mailed Critical | 24 Jun, 2024 | US8303986 |
Expire Patent Critical | 22 May, 2023 | US7927624 |
Maintenance Fee Reminder Mailed Critical | 05 Dec, 2022 | US7927624 |
Payment of Maintenance Fee, 8th Year, Large Entity | 21 Apr, 2020 | US8303986 |
Payment of Maintenance Fee, 8th Year, Large Entity | 09 Oct, 2018 | US7927624 |
Recordation of Patent Grant Mailed Critical | 06 Nov, 2012 | US8303986 |
Patent Issue Date Used in PTA Calculation Critical | 06 Nov, 2012 | US8303986 |
Email Notification Critical | 18 Oct, 2012 | US8303986 |
Issue Notification Mailed Critical | 17 Oct, 2012 | US8303986 |
Dispatch to FDC | 02 Oct, 2012 | US8303986 |
Ropinirole Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Ropinirole Hydrochloride Generic API Manufacturers
Several generic applications have been filed for Ropinirole Hydrochloride. The first generic version for Ropinirole Hydrochloride was by Cosette Pharmaceuticals Inc and was approved on May 5, 2008. And the latest generic version is by Prinston Pharmaceutical Inc and was approved on May 11, 2022.
Given below is the list of companies who have filed for Ropinirole Hydrochloride generic, along with the locations of their manufacturing plants worldwide.
1. ACCORD HLTHCARE
Accord Healthcare Inc has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 0.25MG BASE | tablet | Prescription | ORAL | AB | Feb 28, 2017 |
EQ 1MG BASE | tablet | Prescription | ORAL | AB | Feb 28, 2017 |
EQ 2MG BASE | tablet | Prescription | ORAL | AB | Feb 28, 2017 |
EQ 3MG BASE | tablet | Prescription | ORAL | AB | Feb 28, 2017 |
EQ 4MG BASE | tablet | Prescription | ORAL | AB | Feb 28, 2017 |
EQ 5MG BASE | tablet | Prescription | ORAL | AB | Feb 28, 2017 |
EQ 0.5MG BASE | tablet | Prescription | ORAL | AB | Feb 28, 2017 |
2. ACTAVIS ELIZABETH
Actavis Elizabeth Llc has filed for 5 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 8MG BASE | tablet, extended release | Prescription | ORAL | AB | May 17, 2012 |
EQ 6MG BASE | tablet, extended release | Prescription | ORAL | AB | May 17, 2012 |
EQ 4MG BASE | tablet, extended release | Prescription | ORAL | AB | May 17, 2012 |
EQ 2MG BASE | tablet, extended release | Prescription | ORAL | AB | May 17, 2012 |
EQ 12MG BASE | tablet, extended release | Prescription | ORAL | AB | May 17, 2012 |
Manufacturing Plant Locations New
Actavis Elizabeth's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Elizabeth as present at those locations.
Country | City | Firm Name | ||
---|---|---|---|---|
United States |
|
3. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 5 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Alembic.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 2MG BASE | tablet, extended release | Prescription | ORAL | AB | Apr 22, 2013 |
EQ 4MG BASE | tablet, extended release | Prescription | ORAL | AB | Apr 22, 2013 |
EQ 6MG BASE | tablet, extended release | Prescription | ORAL | AB | Apr 22, 2013 |
EQ 12MG BASE | tablet, extended release | Prescription | ORAL | AB | Apr 22, 2013 |
EQ 8MG BASE | tablet, extended release | Prescription | ORAL | AB | Apr 22, 2013 |
Manufacturing Plant Locations New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
Country | City | Firm Name | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
India |
|
4. ALEMBIC LTD
Alembic Ltd has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Alembic Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 4MG BASE | tablet | Prescription | ORAL | AB | Mar 24, 2010 |
EQ 5MG BASE | tablet | Prescription | ORAL | AB | Mar 24, 2010 |
EQ 0.25MG BASE | tablet | Prescription | ORAL | AB | Mar 24, 2010 |
EQ 0.5MG BASE | tablet | Prescription | ORAL | AB | Mar 24, 2010 |
EQ 1MG BASE | tablet | Prescription | ORAL | AB | Mar 24, 2010 |
EQ 2MG BASE | tablet | Prescription | ORAL | AB | Mar 24, 2010 |
EQ 3MG BASE | tablet | Prescription | ORAL | AB | Mar 24, 2010 |
5. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 10 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 4MG BASE | tablet, extended release | Prescription | ORAL | AB | Aug 27, 2012 |
EQ 0.25MG BASE | tablet | Prescription | ORAL | AB | May 29, 2008 |
EQ 0.5MG BASE | tablet | Prescription | ORAL | AB | May 29, 2008 |
EQ 1MG BASE | tablet | Prescription | ORAL | AB | May 29, 2008 |
EQ 2MG BASE | tablet, extended release | Prescription | ORAL | AB | Aug 27, 2012 |
EQ 3MG BASE | tablet | Prescription | ORAL | AB | May 29, 2008 |
EQ 5MG BASE | tablet | Prescription | ORAL | AB | May 29, 2008 |
EQ 6MG BASE | tablet, extended release | Prescription | ORAL | AB | Aug 27, 2012 |
EQ 8MG BASE | tablet, extended release | Prescription | ORAL | AB | Aug 27, 2012 |
EQ 12MG BASE | tablet, extended release | Prescription | ORAL | AB | Aug 27, 2012 |
6. COSETTE
Cosette Pharmaceuticals Inc has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Cosette.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 0.5MG BASE | tablet | Discontinued | ORAL | N/A | May 5, 2008 |
EQ 0.25MG BASE | tablet | Discontinued | ORAL | N/A | May 5, 2008 |
EQ 1MG BASE | tablet | Discontinued | ORAL | N/A | May 5, 2008 |
EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | May 5, 2008 |
EQ 3MG BASE | tablet | Discontinued | ORAL | N/A | May 5, 2008 |
EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | May 5, 2008 |
EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | May 19, 2008 |
Manufacturing Plant Locations New
Cosette's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Cosette as present at those locations.
Country | City | Firm Name | ||||
---|---|---|---|---|---|---|
United States |
|
7. DR REDDYS LABS LTD
Dr Reddys Laboratories Ltd has filed for 5 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 2MG BASE
(reference standard) | tablet, extended release | Prescription | ORAL | AB | Jun 6, 2012 |
EQ 4MG BASE | tablet, extended release | Prescription | ORAL | AB | Jun 6, 2012 |
EQ 6MG BASE | tablet, extended release | Prescription | ORAL | AB | Jun 6, 2012 |
EQ 8MG BASE | tablet, extended release | Prescription | ORAL | AB | Jun 6, 2012 |
EQ 12MG BASE | tablet, extended release | Prescription | ORAL | AB | Jun 6, 2012 |
8. EPIC PHARMA LLC
Epic Pharma Llc has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Epic Pharma Llc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 1MG BASE | tablet | Discontinued | ORAL | N/A | May 20, 2008 |
EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | May 20, 2008 |
EQ 3MG BASE | tablet | Discontinued | ORAL | N/A | May 20, 2008 |
EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | May 20, 2008 |
EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | May 20, 2008 |
EQ 0.25MG BASE | tablet | Discontinued | ORAL | N/A | May 20, 2008 |
EQ 0.5MG BASE | tablet | Discontinued | ORAL | N/A | May 20, 2008 |
9. GLENMARK PHARMS LTD
Glenmark Pharmaceuticals Ltd has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 0.25MG BASE | tablet | Prescription | ORAL | AB | Feb 25, 2010 |
EQ 0.5MG BASE | tablet | Prescription | ORAL | AB | Feb 25, 2010 |
EQ 1MG BASE | tablet | Prescription | ORAL | AB | Feb 25, 2010 |
EQ 2MG BASE | tablet | Prescription | ORAL | AB | Feb 25, 2010 |
EQ 3MG BASE | tablet | Prescription | ORAL | AB | Feb 25, 2010 |
EQ 4MG BASE | tablet | Prescription | ORAL | AB | Feb 25, 2010 |
EQ 5MG BASE | tablet | Prescription | ORAL | AB | Feb 25, 2010 |
10. HIKMA
Hikma Pharmaceuticals Usa Inc has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Hikma.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 0.25MG BASE | tablet | Discontinued | ORAL | N/A | May 5, 2008 |
EQ 0.5MG BASE | tablet | Discontinued | ORAL | N/A | May 5, 2008 |
EQ 1MG BASE | tablet | Discontinued | ORAL | N/A | May 5, 2008 |
EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | May 5, 2008 |
EQ 3MG BASE | tablet | Discontinued | ORAL | N/A | May 5, 2008 |
EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | May 5, 2008 |
EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | May 19, 2008 |
Manufacturing Plant Locations New
Hikma's manufacturing plants are situated in 3 countries - United States, Portugal, Jordan. Given below are the details of these plant locations as well as the firm names of Hikma as present at those locations.
Country | City | Firm Name | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
United States |
| |||||||||
Portugal |
| |||||||||
Jordan |
|
11. MLV
Mlv Pharma Llc has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Mlv.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 5MG BASE | tablet | Prescription | ORAL | AB | Feb 7, 2012 |
EQ 4MG BASE | tablet | Prescription | ORAL | AB | Feb 7, 2012 |
EQ 3MG BASE | tablet | Prescription | ORAL | AB | Feb 7, 2012 |
EQ 2MG BASE | tablet | Prescription | ORAL | AB | Feb 7, 2012 |
EQ 1MG BASE | tablet | Prescription | ORAL | AB | Feb 7, 2012 |
EQ 0.5MG BASE | tablet | Prescription | ORAL | AB | Feb 7, 2012 |
EQ 0.25MG BASE | tablet | Prescription | ORAL | AB | Feb 7, 2012 |
12. MYLAN PHARMS INC
Mylan Pharmaceuticals Inc has filed for 6 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Mylan Pharms Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 3MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Oct 15, 2012 |
EQ 4MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Oct 15, 2012 |
EQ 6MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Oct 15, 2012 |
EQ 8MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Oct 15, 2012 |
EQ 12MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Oct 15, 2012 |
EQ 2MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Oct 15, 2012 |
13. NORVIUM BIOSCIENCE
Norvium Bioscience Llc has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 0.25MG BASE | tablet | Discontinued | ORAL | N/A | May 5, 2008 |
EQ 0.5MG BASE | tablet | Discontinued | ORAL | N/A | May 5, 2008 |
EQ 1MG BASE | tablet | Discontinued | ORAL | N/A | May 5, 2008 |
EQ 2MG BASE | tablet | Discontinued | ORAL | N/A | May 5, 2008 |
EQ 3MG BASE | tablet | Discontinued | ORAL | N/A | May 5, 2008 |
EQ 4MG BASE | tablet | Discontinued | ORAL | N/A | May 5, 2008 |
EQ 5MG BASE | tablet | Discontinued | ORAL | N/A | May 19, 2008 |
14. ORBION PHARMS
Orbion Pharmaceuticals Private Ltd has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Orbion Pharms.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 0.25MG BASE | tablet | Prescription | ORAL | AB | Nov 28, 2012 |
EQ 0.5MG BASE | tablet | Prescription | ORAL | AB | Nov 28, 2012 |
EQ 1MG BASE | tablet | Prescription | ORAL | AB | Nov 28, 2012 |
EQ 2MG BASE | tablet | Prescription | ORAL | AB | Nov 28, 2012 |
EQ 3MG BASE | tablet | Prescription | ORAL | AB | Nov 28, 2012 |
EQ 4MG BASE | tablet | Prescription | ORAL | AB | Nov 28, 2012 |
EQ 5MG BASE | tablet | Prescription | ORAL | AB | Nov 28, 2012 |
15. PRINSTON INC
Prinston Pharmaceutical Inc has filed for 10 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Prinston Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 0.25MG BASE
(reference standard) | tablet | Prescription | ORAL | AB | May 5, 2008 |
EQ 0.5MG BASE | tablet | Prescription | ORAL | AB | May 5, 2008 |
EQ 1MG BASE | tablet | Prescription | ORAL | AB | May 5, 2008 |
EQ 2MG BASE | tablet, extended release | Prescription | ORAL | AB | May 11, 2022 |
EQ 3MG BASE | tablet | Prescription | ORAL | AB | May 5, 2008 |
EQ 4MG BASE | tablet, extended release | Prescription | ORAL | AB | May 11, 2022 |
EQ 5MG BASE | tablet | Prescription | ORAL | AB | Jul 11, 2008 |
EQ 6MG BASE | tablet, extended release | Prescription | ORAL | AB | May 11, 2022 |
EQ 8MG BASE | tablet, extended release | Prescription | ORAL | AB | May 11, 2022 |
EQ 12MG BASE | tablet, extended release | Prescription | ORAL | AB | May 11, 2022 |
16. SANDOZ INC
Sandoz Inc has filed for 5 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Sandoz Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 2MG BASE | tablet, extended release | Prescription | ORAL | AB | Jun 6, 2012 |
EQ 4MG BASE | tablet, extended release | Prescription | ORAL | AB | Jun 6, 2012 |
EQ 6MG BASE | tablet, extended release | Prescription | ORAL | AB | Jun 6, 2012 |
EQ 8MG BASE | tablet, extended release | Prescription | ORAL | AB | Jun 6, 2012 |
EQ 12MG BASE | tablet, extended release | Prescription | ORAL | AB | Jun 6, 2012 |
Manufacturing Plant Locations New
Sandoz Inc's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Sandoz Inc as present at those locations.
Country | City | Firm Name | ||||
---|---|---|---|---|---|---|
United States |
|
17. WATSON LABS INC
Watson Laboratories Inc has filed for 5 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Watson Labs Inc.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 2MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Jun 6, 2012 |
EQ 4MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Jun 6, 2012 |
EQ 6MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Jun 6, 2012 |
EQ 8MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Jun 6, 2012 |
EQ 12MG BASE | tablet, extended release | Discontinued | ORAL | N/A | Jun 6, 2012 |
18. ZYDUS LIFESCIENCES
Zydus Lifesciences Ltd has filed for 7 different strengths of generic version for Ropinirole Hydrochloride. Given below are the details of the strengths of this generic introduced by Zydus Lifesciences.
Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
---|---|---|---|---|---|
EQ 4MG BASE | tablet | Prescription | ORAL | AB | Jun 1, 2009 |
EQ 2MG BASE | tablet | Prescription | ORAL | AB | Jun 1, 2009 |
EQ 1MG BASE | tablet | Prescription | ORAL | AB | Jun 1, 2009 |
EQ 0.5MG BASE | tablet | Prescription | ORAL | AB | Jun 1, 2009 |
EQ 0.25MG BASE | tablet | Prescription | ORAL | AB | Jun 1, 2009 |
EQ 5MG BASE | tablet | Prescription | ORAL | AB | Jun 1, 2009 |
EQ 3MG BASE | tablet | Prescription | ORAL | AB | Jun 1, 2009 |
Manufacturing Plant Locations New
Zydus Lifesciences's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Zydus Lifesciences as present at those locations.
Country | City | Firm Name | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
India |
|